- /
- Supported exchanges
- / US
- / CNTB.NASDAQ
Connect Biopharma Holdings Ltd (CNTB NASDAQ) stock market data APIs
Connect Biopharma Holdings Ltd Financial Data Overview
Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for the treatment of acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). The company was founded in 2012 and is headquartered in San Diego, California.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Connect Biopharma Holdings Ltd data using free add-ons & libraries
Get Connect Biopharma Holdings Ltd Fundamental Data
Connect Biopharma Holdings Ltd Fundamental data includes:
- Net Revenue: 233 K
- EBITDA: -65 539 000
- Earnings Per Share: -1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Connect Biopharma Holdings Ltd Earnings data
Corporate Events Calendar & News package for
What’s included:
- Latest Release: 2026-04-01
- EPS/Forecast: -0.2825
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Connect Biopharma Holdings Ltd News
New
Pre-Market Movers: PMI, CNTB, RNAZ Chart The Course
(RTTNews) - Pre-market trading is offering an early glimpse into biotech stocks likely to attract investor attention this Wednesday. Significant price moves ahead of the opening bell are being driven...
Connect Biopharma to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference
SAN DIEGO, May 12, 2026 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect or the Company), a clinical-stage biopharmaceutical company focused on trans...
Weekly Buzz: SPRY Gains FDA Nod; EU Expands Kerendia Label; LLY Acquires CNTA; BIIB Snaps Up APLS
(RTTNews) - This week's biotech landscape witnessed regulatory approvals across the U.S., EU, and China, acquisitions, a few key trial goal misses and positive clinical trial data readouts across ther...
Connect Biopharma Shares Jump 13% After Positive Rademikibart Data And $20.2 Million Financing
(RTTNews) - Connect Biopharma Holding Limited (CNTB) surged 13% in pre-market trading Monday after the company issued three major announcements, including positive clinical data for Rademikibart in as...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.